谷歌浏览器插件
订阅小程序
在清言上使用

Long-term Efficacy and Safety of Continued Complement C1s Inhibition with Sutimlimab in Cold Agglutinin Disease: CADENZA Study Part B

EClinicalMedicine(2024)

引用 0|浏览2
关键词
Autoimmune haemolytic anaemia,Cold agglutinin disease,Classical complement pathway,Complement C1s,Sutimlimab,Haemolysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要